Robert Thomas - TriVascular Technologies Independent Director

Director

Mr. Robert W. Thomas is Independent Director of TriVascular Technologies Inc. Mr. Thomas served as our interim executive chairman from January 2012 to April 2012. Mr. Thomas has served as a Venture Partner at Aphelion Capital LLC or Aphelion since March 2013. Prior to joining Aphelion Mr. Thomas served as Chief Executive Officer at Foxhollow Technologies Inc. from 1998 to 2006. Mr. Thomas also currently serves on the board of directors of Corium International Inc. and has served on the boards of four other private companies in the past five years since 2008.
Age 52
Tenure 16 years
Phone707-543-8800
Webhttp://www.trivascular.com
Thomas received his B.A. degree in Economics from Ursinus College. We believe that Mr. Thomas’ extensive knowledge and experience from serving as CEO of a public company and as an investor in companies at various stages of development qualify him to serve on our Board.

TriVascular Technologies Management Efficiency

The company has return on total asset (ROA) of (0.574) % which means that it has lost $0.574 on every $100 spent on assets. This is way below average. TriVascular Technologies' management efficiency ratios could be used to measure how well TriVascular Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 55 M in liabilities with Debt to Equity (D/E) ratio of 1.74, which is about average as compared to similar companies. TriVascular Technologies has a current ratio of 6.98, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist TriVascular Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, TriVascular Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like TriVascular Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TriVascular to invest in growth at high rates of return. When we think about TriVascular Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Laurel KrzeminskiArrow Electronics
66
Martha KeethArrow Electronics
73
John HansonArrow Electronics
74
Randall WaterfieldAsure Software
43
Philip AshermanArrow Electronics
67
Charles LathropAsure Software
61
Thomas PistorEvertz Technologies Limited
N/A
Matthew BehrentAsure Software
46
Steven OBrienArrow Electronics
N/A
Andrew KerinArrow Electronics
57
Rakesh PatelEvertz Technologies Limited
51
Ian McWalterEvertz Technologies Limited
58
Stephen PatrickArrow Electronics
71
Adrian PertierraAsure Software
45
Ye CFAParanovus Entertainment Technol
46
Brian PiccioniEvertz Technologies Limited
N/A
Daniel GillAsure Software
53
Brad BurrowsAsure Software
N/A
William AustenArrow Electronics
62
Barry PerryArrow Electronics
74
Fabian GarciaArrow Electronics
61
TriVascular Technologies, Inc., a medical device company, develops and commercializes technologies to advance minimally invasive treatment of abdominal aortic aneurysms . TriVascular Technologies (TRIV) is traded on NASDAQ Exchange in USA and employs 307 people.

Management Performance

TriVascular Technologies Leadership Team

Elected by the shareholders, the TriVascular Technologies' board of directors comprises two types of representatives: TriVascular Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TriVascular. The board's role is to monitor TriVascular Technologies' management team and ensure that shareholders' interests are well served. TriVascular Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TriVascular Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jake Nunn, Independent Director
Christopher Chavez, Chairman, CEO and Pres
Ryan Drant, Independent Director
Michael Kramer, CFO and Principal Accounting Officer
Kimberley Elting, Chief Compliance Officer, VP of Corporate Affairs, General Counsel and Secretary
Daniel Moore, Independent Director
James Scopa, Independent Director
Vivek Jayaraman, Vice President - Global Sales and Marketing
Louis Molinari, Vice President - Manufacturing Operations
Robert Whirley, Co-Founder and VP of RandD
Robert Thomas, Independent Director
Michael Chobotov, Co-Founder and CTO
Douglas Roeder, Independent Director
Shari OQuinn, Vice President - Clinical/Regulatory Affairs and Quality

TriVascular Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is TriVascular Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in TriVascular Stock

If you are still planning to invest in TriVascular Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TriVascular Technologies' history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk